1. Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21:89–103.
2. Håkonsen H, Horn AM, Toverud EL. Price control as a strategy for pharmaceutical cost containment — what has been achieved in Norway in the period 1994–2004? Health Policy. 2009;90:277–285.
3. The Norwegian Association of Pharmaceutical Manufacturers. Facts and Figures 2009. Available at: www.legemiddelstatistikk.com/tf/2009/english/chap_2/203.html. Accessed January 20, 2010.
4. LIS (Drug Procurement Cooperation). Annual report 2008. Available at: www.lisnorway.no/lisnorway/vedlegg/LIS-RHF-rapport-2008-til-hjemmesiden-Rev-29.06-KRF.doc. Accessed January 20, 2010.
5. Ministry of Health and Care Services. FOR-2008-04-03-320: Forskrift om legemiddelhåndtering for virksomheter og helsepersonell som yter helsehjelp [in Norwegian]. Oslo, Norway: Ministry of Health and Care Services; 2008.